We're proud to receive a 2025 CDMO Leadership Award in the “Small Molecule Dosage Form” global category.
Fixed-dose combination drugs are increasing in popularity due to their clinical benefits over monotherapy alternatives, but there are also several business advantages drug sponsors can derive from utilizing a combination drug strategy. Download the infographic to learn more.